Treace Medical Concepts Inc (NAS:TMCI)
$ 5.29 -0.15 (-2.76%) Market Cap: 328.99 Mil Enterprise Value: 313.12 Mil PE Ratio: 0 PB Ratio: 2.94 GF Score: 39/100

Treace Medical Concepts Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 12:35PM GMT
Release Date Price: $22.33 (-4.37%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Good morning, everyone. Welcome to another session at the Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the medical device analysts here. Before we jump into it, just an important disclosure, please see Morgan Stanley Research Disclosure website at morganstanley/research disclosures. If you have any questions, please reach out to your Morgan Stanley sales reps. But I'm thrilled to have the CEO of Treace Medical here, John Treace. It's great to finally meet really or see each other in person. But before we kind of kick it off to get the -- share your disclosure.

John T. Treace
Treace Medical Concepts, Inc. - CEO, Founder & Director

Sure. Well, first of all, Drew, thanks for having us. It's a real pleasure to be here. We're very excited. I did want to refer everybody to our forward-looking statement disclosures available on our website and in our filings.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot